myirislogo
01 February, 2023 20:15 IST
Earnings
Top Stories
Strides Pharma gets USFDA approval for Colchicine Tablets
Strides Pharma Science, (Strides), a pharmaceutical company manufacturing IP-led niche products, on March 11, announced that its stepdown wholly owned subsidiary, Strides Pharma Global Pte.,
11-Mar-2022 18:16
more...
Corporate
Strides Pharma gets USFDA approval for Colchicine Tablets
Strides Pharma Science, (Strides), a pharmaceutical company manufacturing IP-led niche products, on March 11, announced that its stepdown wholly owned subsidiary, Strides Pharma Global Pte.,
11-Mar-2022 18:16
more...
JK Paper Q3FY22 Review-In-line quarter, promising outlook
JK Paper (JK Paper) Q3FY22 result was in-line with our estimates on key parameters. Healthy demand and price hike supported net sales growth, while prudent cost control aided operating margin expansio
02-Feb-2022 14:32
    more...
    Ind-Ra upgrades Jindal Stainless to 'IND AA-'
    India Ratings and Research (Ind-Ra) has upgraded the long-term issuer rating assigned to Jindal Stainless (JSL) to 'IND AA-' with a stable outlook, while resolving the Rating Watch Evolving (RWE). The  02-Feb-2022 14:32
    more...
    Economy
    General
    Key highlights of Union Budget 2022-23
         Finance Minsister Nirmala Sitharaman on Tuesday presented Union Budget 2022-23. Here are the key highlights: >India Economic Growth in FY22 to be at 9.2%, says Finance Minister&  01-Feb-2022 12:07
    more...
    Sector
    Zydus gets final nod from USFDA for Nitroglycerin Sublingual Tablets
    Zydus Lifesciences has received final approval from the USFDA to market Nitroglycerin Sublingual Tablets in the strengths of 0.3 mg, 0.4mg and 0.6mg (US RLD: Nitrostat Sublingual Tablets). Nitroglycer  10-Mar-2022 17:47
      more...
      Investing News
      Supriya Lifescience makes stellar debut; lists at 55% premium
      Supriya Lifescience, a pharma API manufacturer, made a stellar debut with 55% gains, listing at Rs 425/share against IPO price of Rs 274, amidst positive market sentiments. It has a niche product port  28-Dec-2021 14:02
      more...